Who we are
We are an international umbrella liver patient-led association. Our purpose is to represent and advocate for all patients affected by liver disease in both policy and operational contexts and promote equal access to effective areas of liver healthcare.
What we do
We undertake activities to improve care and treatment for people who are affected by, or at the risk, of a liver condition. We work in a progressive and collaborative way, ensuring meaningful engagement and partnerships with other stakeholders.
Become a member
Together we will be able to support, develop and lead increased patient support and advocacy, playing a crucial role in shaping the policy of global
health strategies and initiatives through partnerships.
Our network
World Hepatitis Day 2024
Every year, 1.3 million people lose their lives to hepatitis. And new data...
The uncertain future of Obeticholic Acid in Europe
More than ever it it is extremely important to include the voice of...
Key messages of World Hepatitis Summit 2024
World Hepatitis Summit 2024 was hosted in Lisbon, Portugal on 9-11 April as an...
EASL Congress 5 – 8 June 2024
From 5-8 June, Milan, Italy will be the home of hepatology! The EASL Congress...
Innovations in Steatotic Liver Disease 3- 4 May 2024
The Innovations in SLD Think-Tank 2024 will take place as an exclusive...
International PBC Summit 9 -12 April 2024
Following the success of last year’s Summit, PBC Foundation will be hosting...
World Hepatitis Summit 9 -14 April 2024
The World Hepatitis Summit (WHS) will take place at Lisbon, Portugal and is...
STEATOTIC LIVER DISEASE
International brochure about Steatotic Liver Disease Here information about...
September 10th is Primary Biliary Cholangitis (PBC) Awareness Day
This year’s theme is “Ask me about PBC”, a conversation starter involving the...
LPI is attending EASL Liver Congress in Vienna
Between June 21 and 24, LPI is going to attend the EASL Congress in Vienna,...